PRP Hair Loss Treatment Preparation Protocol: The 5-Stage Blood-to-Scalp Process Decoded
Introduction: Why Most PRP Explanations Leave Patients More Confused Than Confident
Walk into most hair restoration clinics asking about PRP, and the explanation typically sounds something like this: “We draw your blood, spin it, and inject it into your scalp.” For a treatment costing $400 to $1,500 or more per session, that explanation leaves patients with more questions than answers.
The reality is far more nuanced—and far more important to understand. PRP results vary dramatically between patients and clinics, and the reason almost always comes down to preparation quality, not the therapy itself. A landmark 2025 systematic review of 43 randomized controlled trials with 1,877 participants confirmed PRP as safe and effective for improving hair density. Yet countless patients report that “PRP didn’t work” for them.
This article decodes the biological why behind each of the five stages of the PRP hair loss treatment preparation protocol—not just the what. It introduces the DEPA classification framework, a tool patients can use to evaluate clinic quality before committing to treatment, and sets realistic expectations from the outset: PRP works, but results depend heavily on protocol execution.
Here is what actually happens—and why every decision in the preparation process matters to the outcome.
What PRP Actually Is — And Why the Patient’s Own Blood Is the Starting Point
PRP stands for Platelet-Rich Plasma—a concentration of platelets derived from the patient’s own blood, used to deliver growth factors directly to hair follicles. The autologous nature of PRP eliminates the risk of allergic reactions, immune rejection, or blood-borne pathogen transmission.
Platelets matter for hair regrowth because they release growth factors—PDGF, VEGF, EGF, and TGF-β—that stimulate dermal papilla cells, extend the anagen (growth) phase, and improve blood supply to follicles. These growth factors are the therapeutic payload that makes PRP effective.
The entire protocol exists to achieve one core biological objective: platelets must remain unactivated during collection and centrifugation, then be delivered in high concentration to the scalp. Every step in the five-stage process serves this goal.
Normal platelet levels range from 150,000 to 450,000 per microliter—a threefold biological variability between patients that partly explains why individual results differ. The clinical target is to achieve two to six times the patient’s baseline platelet concentration, reaching approximately one to 1.5 million platelets per microliter in the final PRP product.
The 5-Stage PRP Preparation Protocol: A Step-by-Step Biological Breakdown
The entire process from blood draw to final injection typically takes 30 to 60 minutes. What follows is a stage-by-stage breakdown of the PRP hair loss treatment preparation protocol with the clinical reasoning behind each step.
Stage 1: Pre-Treatment Patient Preparation — Setting the Biological Stage
Patient preparation begins days before the appointment—not in the clinic chair—and directly affects PRP quality.
NSAID discontinuation (7–10 days prior): Aspirin, ibuprofen, and naproxen inhibit platelet function by blocking thromboxane A2 synthesis. Platelets collected from a patient still taking NSAIDs will be less responsive and release fewer growth factors.
Blood-thinning supplements (stop 7–14 days prior): Vitamin E, fish oil, garlic, and ginkgo biloba all have antiplatelet or anticoagulant properties that can reduce platelet aggregation capacity.
Hydration (drink 500 mL of water at least 2 hours before): Adequate hydration improves blood volume and makes venipuncture easier, reducing the chance of a difficult draw that could mechanically activate platelets.
Eating a normal meal: This prevents vasovagal response (fainting) during the blood draw; low blood sugar can also affect platelet behavior.
Washing hair the morning of the procedure with no styling products: This ensures a clean scalp surface for injection and reduces infection risk.
Avoiding alcohol for at least 2 days prior: Alcohol affects platelet function and can cause dehydration.
Pre-treatment preparation is not administrative box-checking—it is biological optimization of the raw material before the protocol even begins.
Stage 2: The Blood Draw — Volume, Needle Gauge, and Anticoagulant Science
The blood draw typically involves 10 to 60 mL (commonly 20 to 60 mL) drawn from the arm via venipuncture, similar to a routine blood test.
Needle gauge selection matters significantly. Large-bore needles (greater than 22 gauge) are used intentionally because smaller needles create turbulent flow and shear stress that can mechanically activate platelets before they reach the collection tube, degrading PRP quality before centrifugation begins.
Blood is collected into tubes pre-loaded with an anticoagulant, most commonly acid citrate dextrose (ACD) or sodium citrate. This is perhaps the most misunderstood step in the entire process.
Platelets are programmed to activate and clump the moment they sense injury or leave the bloodstream. Anticoagulants work by chelating (binding) calcium ions—calcium is required for the platelet activation cascade. Without available calcium, platelets remain in a dormant, unactivated state throughout collection and centrifugation.
If platelets activate prematurely in the tube, they release their growth factors into the plasma before injection—meaning the patient receives growth-factor-depleted PRP at the scalp. The anticoagulant preserves the growth factor payload for delivery at the target site.
A 30 cc blood draw typically yields 3 to 5 cc of final PRP product, depending on individual platelet count, device, and technique.
Stage 3: Centrifugation — Single Spin vs. Double Spin and Why It Changes Everything
Centrifugation uses centrifugal force to separate blood into three distinct layers by density: packed red blood cells (bottom), the platelet-rich “buffy coat” layer (middle), and platelet-poor plasma (top). The PRP layer is then carefully extracted using a syringe.
The single-spin versus double-spin debate represents one of the most clinically significant variables in PRP preparation:
Single-spin centrifugation: One spin at a lower speed (typically 1,500 to 2,000 RPM for 10 to 15 minutes) separates red blood cells from plasma. This approach is simpler, faster, and gentler on platelets—but typically yields lower platelet concentration.
Double-spin centrifugation: A first spin separates red blood cells; the plasma layer is then transferred and spun again at higher speed to further concentrate platelets. This produces higher platelet concentration but risks platelet activation from mechanical stress if speed is excessive.
Centrifugation speed and duration directly determine whether the final product achieves the therapeutic two-to-six-times platelet concentration threshold. Under-spinning produces dilute PRP; over-spinning can damage or prematurely activate platelets.
Not all centrifuge systems are equal. Commercial closed-system devices used in reputable clinics are calibrated and validated; open systems with improvised protocols produce inconsistent results. This is a primary reason why reported PRP failures often reflect preparation quality rather than therapy failure.
No universally standardized protocol exists as of 2026—variability in centrifugation speed, spin number, blood volume, and tube type leads to wide variation in platelet concentration across clinics.
Stage 4: Platelet Activation — The Debated Step That May Determine Results
Platelet activation means triggering platelets to release their alpha granule contents—the growth factors (PDGF, VEGF, TGF-β, EGF, IGF) that stimulate follicular regeneration.
Two clinical approaches exist: activated PRP (an exogenous activator is added before injection) versus non-activated PRP (injected as-is, relying on the body’s natural tissue environment to trigger activation).
Activation is achieved by adding calcium chloride or calcium gluconate to the PRP—reintroducing the calcium ions that were chelated by the anticoagulant in Stage 2, thereby triggering the platelet activation cascade.
A 2025 meta-analysis found that activated PRP was more effective at increasing hair density and minimizing recurrence compared to non-activated PRP. However, some clinicians argue that natural tissue activation—triggered by the needle trauma of injection itself—is sufficient, and that pre-activation risks releasing growth factors before the PRP reaches the target follicle.
A clinic that uses activation is not necessarily superior to one that does not—but a clinic that holds a reasoned, evidence-based position on this question demonstrates protocol sophistication.
Stage 5: Scalp Injection — Precision Delivery to the Target Follicles
Local anesthesia or nerve blocks are typically administered first to minimize discomfort, as multiple injections across the scalp are required.
This precision matters because the target is the dermal papilla—the cluster of cells at the base of the hair follicle that controls the hair growth cycle. Injections too shallow miss the target; injections too deep waste PRP in subcutaneous tissue where it has no follicular effect.
A 30 cc blood draw yielding 3 to 5 cc of PRP must be distributed efficiently across the treatment area, which is why injection mapping and technique are not trivial considerations.
Mild scalp tenderness, redness, and swelling at injection sites are normal and typically resolve within 2 to 5 days—signs that the inflammatory response PRP is designed to harness is underway.
The DEPA Classification: How to Evaluate Any Clinic’s PRP Protocol Before Committing
The DEPA classification system provides a practical framework for evaluating PRP quality:
D — Dose: How many platelets are actually being delivered? A clinic should be able to state the target platelet concentration (ideally one to 1.5 million per microliter, or two to six times baseline). If they cannot answer this question, they may not be measuring it.
E — Efficiency: What percentage of the platelets from the original blood draw survive into the final PRP product? Higher efficiency means less platelet loss during centrifugation.
P — Purity: What is the ratio of platelets to red blood cells and white blood cells in the final product? Red blood cell contamination can cause local inflammatory reactions.
A — Activation: Does the clinic use an activator (calcium chloride or calcium gluconate)? If so, when and at what concentration? If not, what is the rationale?
Asking these four questions before booking a PRP session can reveal a clinic’s protocol quality. Many reported PRP failures are attributable to low DEPA-quality protocols—subtherapeutic platelet doses, high red blood cell contamination, or premature activation—not to PRP as a therapy.
Baseline Platelet Count: The Biological Variable Clinics Rarely Discuss
Normal platelet levels range from 150,000 to 450,000 per microliter—a threefold variation between individuals that is entirely normal and unrelated to health status.
A patient with 150,000 platelets per microliter at baseline will produce significantly less concentrated PRP from the same blood volume and centrifugation protocol as a patient with 450,000 per microliter at baseline.
Some advanced clinics perform a baseline CBC (complete blood count) before the first PRP session to understand the patient’s starting platelet count and calibrate the protocol accordingly. A clinic that does not assess baseline platelet count is applying a one-size-fits-all protocol to a biologically variable situation.
Patients with lower baseline platelet counts may require more sessions, higher blood draw volumes, or combination therapies to achieve comparable results. Clinical studies report a 70 to 80 percent success rate for patients with early-to-moderate hair loss and a 31 percent average increase in hair density at six months—but these averages mask significant individual variation.
What to Realistically Expect: Timeline, Results, and the Maintenance Commitment
The most common patient disappointment stems from expecting results too soon and abandoning treatment before the biological process has time to work.
Visible improvement can appear as early as one to two months, but three months is the minimum before any meaningful change is typically noticeable. Maximum improvement may take up to 12 months.
The standard induction protocol involves three to four sessions spaced four to six weeks apart. Effects typically last 12 to 18 months before maintenance sessions are needed; relapse may occur 12 to 16 months after the last treatment. PRP is not a one-time cure—it is an ongoing maintenance therapy.
PRP is best suited for patients with early-to-moderate hair loss (Norwood-Hamilton scale I–III). Completely bald areas with no surviving follicles are unlikely to respond—active follicle miniaturization must be present for PRP to be effective.
Combination therapy (PRP plus minoxidil plus finasteride, or PRP plus microneedling) consistently outperforms PRP monotherapy in clinical studies. PRP is also increasingly used during or after hair transplant surgery to improve graft survival, reduce shock loss, and accelerate the anagen phase.
Post-Treatment Care: Why Anti-Inflammatories Must Be Avoided After PRP
Patients are routinely advised to avoid NSAIDs after PRP, but the biological reasoning is rarely explained.
PRP works by triggering a controlled inflammatory response. The growth factors released by platelets initiate a healing cascade in which inflammation is a necessary first step. Taking anti-inflammatory medications—ibuprofen, aspirin, naproxen—after PRP suppresses this very response, working against the treatment.
Additional post-treatment instructions include avoiding alcohol, caffeine, and smoking for 72 hours; avoiding saunas, steam rooms, and swimming for two days; avoiding hair coloring and chemical treatments for three to 14 days; avoiding strenuous exercise and scalp massage for 24 to 48 hours; and waiting 24 hours before washing hair.
Mild scalp tenderness, redness, and swelling lasting two to five days are normal and expected—they indicate the inflammatory response is active, which is the desired outcome.
Who Should Not Get PRP: Contraindications Explained With Clinical Reasoning
Understanding the clinical reasoning behind contraindications helps patients self-screen appropriately.
Active blood thinner use (Plavix, Coumadin, Heparin): These medications prevent the platelet aggregation and clotting that PRP depends on. The treatment cannot function as intended, and injection-site bleeding risk is elevated.
Blood disorders and platelet abnormalities: If a patient’s platelets are insufficient in number or function, the PRP product will be subtherapeutic regardless of protocol quality.
Active scalp skin cancer: Injecting growth factors into a cancerous area risks stimulating tumor cell proliferation—an absolute contraindication.
Systemic cancer or active chemotherapy: Chemotherapy suppresses platelet production, and growth factor stimulation is contraindicated in oncology contexts.
Pregnancy: Insufficient safety data exists; the precautionary principle applies.
PRP equipment is FDA-cleared, but PRP for hair loss is an off-label use—meaning the FDA has not specifically approved it for this indication. This is common in medicine and does not mean the treatment is unsafe or experimental. PRP is not covered by insurance as a hair loss treatment.
Conclusion: The Protocol Is the Treatment
PRP is not a single standardized treatment—it is a preparation-dependent therapy in which the quality of the protocol determines the quality of the outcome.
The five-stage framework—pre-treatment preparation, blood draw with anticoagulant, centrifugation (single versus double spin), platelet activation decision, and precision scalp injection—represents a series of decisions that directly affect therapeutic results.
The DEPA framework provides a practical evaluation tool: before committing to any clinic, patients should ask about Dose, Efficiency, Purity, and Activation. A clinic that can answer these questions clearly is demonstrating protocol quality.
In many cases where patients report that “PRP didn’t work,” the therapy did not fail—the protocol did. Understanding preparation quality helps patients make better provider choices and set realistic expectations.
Individual biological variability—baseline platelet count, hair loss stage, and overall health—all influence results, making a personalized consultation with a qualified specialist an essential first step.
Explore PRP Hair Loss Treatment: Start With a Personalized Consultation
At Hair Transplant Specialists (INeedMoreHair.com), protocol quality and patient education are priorities—not just procedure volume. The team includes board-certified surgeons such as Dr. Sharon Keene, former ISHRS President (2014–2015), and colleagues with combined experience exceeding 100 years.
PRP at Hair Transplant Specialists is offered as part of a comprehensive hair restoration approach—not as a standalone commodity treatment. It can be combined with surgical options (FUE, FUT), Alma TED, LLLT, finasteride, and minoxidil based on individual patient needs.
Patients interested in learning more can schedule a consultation at the Eagan, Minnesota location (2121 Cliff Dr. Suite 210, Eagan, MN 55122) or with Dr. Stoller on Long Island. Contact the office at (651) 393-5399 or visit INeedMoreHair.com. Office hours are Monday through Thursday, 9 AM to 5 PM; Friday, 9 AM to 3 PM; weekends by appointment.
